| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/17/2002 | WO2002004626A1 Fungal cell wall synthesis gene |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004497A2 Multiple antigenic peptides immunogenic against streptococcus pneumoniae |
| 01/17/2002 | WO2002004496A2 Fimh adhesin proteins and methods of use |
| 01/17/2002 | WO2002004495A2 Streptococcus pyogenes antigen |
| 01/17/2002 | WO2002004493A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/17/2002 | WO2002004492A2 Herpes zinc finger motifs |
| 01/17/2002 | WO2002004487A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 01/17/2002 | WO2002004478A1 Anti-mycobacterial compounds |
| 01/17/2002 | WO2002004464A1 Novel cephalosporin compounds and process for preparing the same |
| 01/17/2002 | WO2002004463A1 Novel cephalosporin compounds and process for preparing the same |
| 01/17/2002 | WO2002004462A1 Oxazinoquinolones useful for the treatment of viral infections |
| 01/17/2002 | WO2002004445A1 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2002004444A2 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2002004443A2 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2002004440A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 01/17/2002 | WO2002004425A2 Viral polymerase inhibitors |
| 01/17/2002 | WO2002004424A1 Pyrazole derivatives |
| 01/17/2002 | WO2002004422A2 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2002004414A1 Pleuromutilin derivatives having antibacterial activity |
| 01/17/2002 | WO2002004407A2 7-substituted tetracycline compounds |
| 01/17/2002 | WO2002004406A2 9-substituted minocycline compounds |
| 01/17/2002 | WO2002004405A2 13-substituted methacycline compounds |
| 01/17/2002 | WO2002004404A2 7,8 and 9-substituted tetracycline compounds |
| 01/17/2002 | WO2002004034A2 Polymer-bound metal-containing compositions |
| 01/17/2002 | WO2002004020A2 Pathogen resistance in organisms |
| 01/17/2002 | WO2002004019A2 Use of strains of the parapox ovis virus against organ fibrosis |
| 01/17/2002 | WO2002004018A2 Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
| 01/17/2002 | WO2002004017A2 Method for preparing oral vaccines |
| 01/17/2002 | WO2002004011A1 Anti-hiv and anti-tumor peptides and fragments of lysozyme |
| 01/17/2002 | WO2002004002A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 01/17/2002 | WO2002004000A1 Potent immunostimulants from microalgae |
| 01/17/2002 | WO2002003998A2 Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 01/17/2002 | WO2002003982A1 Antimycotic pharmaceutical |
| 01/17/2002 | WO2002003980A1 Anti-inflammatory and analgesic agents |
| 01/17/2002 | WO2002003971A2 Pharmaceutical composition and method for the treatment of retroviral infections |
| 01/17/2002 | WO2002003961A1 Microspheres and adjuvants for dna vaccine delivery |
| 01/17/2002 | WO2002003910A2 Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation |
| 01/17/2002 | WO2002003899A1 Method and manufacture of a wound dressing for covering an open wound |
| 01/17/2002 | WO2002003896A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 01/17/2002 | WO2002003886A1 Treatment of human herpesviruses using hyperthermia |
| 01/17/2002 | WO2002003813A1 Use of dammarane-type triterpenoid saponins |
| 01/17/2002 | WO2001060346A3 Nutritional formulation containing prebiotic substances |
| 01/17/2002 | WO2001052791A3 Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents |
| 01/17/2002 | WO2001047543A3 Activation and inhibition of the immune system |
| 01/17/2002 | WO2001044448A3 Human oxidoreductase proteins |
| 01/17/2002 | WO2001042299A3 Hepatitis virus sentinel virus i (svi) |
| 01/17/2002 | WO2001041782A3 Method for administering a cytokine to the central nervous system and the lymphatic system |
| 01/17/2002 | WO2001040242A3 6-o-methylerythromycin a crystal form iii |
| 01/17/2002 | WO2001031051A3 Antisense modulation of protein kinase c-theta expression |
| 01/17/2002 | WO2001027144A3 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 01/17/2002 | WO2001022972A3 Immunostimulatory nucleic acids |
| 01/17/2002 | WO2001012598A3 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 01/17/2002 | WO2001010468A3 Drug-carrier complexes and methods of use thereof |
| 01/17/2002 | WO2001007471A3 Cell cycle and proliferation proteins |
| 01/17/2002 | WO2001007087A3 Enzyme catalyzed anti-infective therapeutic agents |
| 01/17/2002 | WO2000078953A3 Human transport proteins |
| 01/17/2002 | WO2000078952A3 Human rna metabolism proteins (rmep) |
| 01/17/2002 | WO1999051284A3 Non-covalent bioconjugates useful for diagnosis and therapy |
| 01/17/2002 | US20020007173 Method of inducing a CTL response |
| 01/17/2002 | US20020007074 Imidazole derivatives having affinity for alpha2 receptors |
| 01/17/2002 | US20020007066 For treatment/prevention of infection of herpes simplex virus, varicella zoster virus, human cytomegalovirus, or epstein-Barr virus; enzyme inhibitors |
| 01/17/2002 | US20020007049 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof |
| 01/17/2002 | US20020006951 Solid-state form of celecoxib having enhanced bioavailability |
| 01/17/2002 | US20020006943 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/17/2002 | US20020006937 4-OXO-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents |
| 01/17/2002 | US20020006903 Genetic engineering |
| 01/17/2002 | US20020006640 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 01/17/2002 | US20020006432 Bifidobacterium in the treatment of inflammatory disease |
| 01/17/2002 | US20020006417 Heating the fill mass, cooling the fill mass, and encapsulating the fill mass into the capsule immediately after cooling; nutrients or drugs such as saquinavir |
| 01/17/2002 | US20020006406 Lysostaphin an anti-staphylococcal agent for parenteral administration to mammals including humans exhibits the biological activity of proteolytic attack against glycincontaining bridges in the cell wall peptidoglycan of |
| 01/17/2002 | US20020006380 Pyrrole derivatives, their preparation and pharmaceutical compositions containing them |
| 01/17/2002 | DE10032538A1 Vakzine gegen Helicobacter pylori Vaccine against Helicobacter pylori |
| 01/17/2002 | DE10031955A1 Curcumin-Derivate mit gegenüber Curcumin verbesserter Wasserlöslichkeit und diese enthaltende Arzneimittel Curcumin derivatives with respect to curcumin improved water solubility and pharmaceutical compositions containing them |
| 01/17/2002 | DE10030781A1 Kombinationspräparate von 3-N-Formylhydroxylaminopropylphosphonsäurederivaten oder 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten mit spezielen pharmazeutischen Wirkstoffen Combination products of 3-N-Formylhydroxylaminopropylphosphonsäurederivaten or 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten special share with pharmaceutical agents |
| 01/17/2002 | CA2658217A1 Expression system |
| 01/17/2002 | CA2427066A1 Method for the recovery and application of human defensins as biologically active proteins for the treatment of infections and other diseases |
| 01/17/2002 | CA2416224A1 Multiple antigenic peptides immunogenic against streptococcus pneumoniae |
| 01/17/2002 | CA2416050A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 01/17/2002 | CA2415569A1 Fungal cell wall synthesis gene |
| 01/17/2002 | CA2415498A1 Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 01/17/2002 | CA2415492A1 Pyrazole derivatives |
| 01/17/2002 | CA2415172A1 13-substituted methacycline compounds |
| 01/17/2002 | CA2415086A1 7,8 and 9-substituted tetracycline compounds |
| 01/17/2002 | CA2415083A1 Anti-hiv and anti-tumor peptides and fragments of lysozyme |
| 01/17/2002 | CA2414926A1 Microspheres and adjuvants for dna vaccine delivery |
| 01/17/2002 | CA2414460A1 Fimh adhesin proteins and methods of use |
| 01/17/2002 | CA2414455A1 Pharmaceutical composition and method for the treatment of retroviral infections |
| 01/17/2002 | CA2414387A1 Drug metabolizing enzymes |
| 01/17/2002 | CA2414374A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/17/2002 | CA2413045A1 Expression system |
| 01/17/2002 | CA2413044A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 01/17/2002 | CA2409337A1 Novel cephalosporin compounds and process for preparing the same |
| 01/17/2002 | CA2409329A1 Novel cephalosporin compounds and process for preparing the same |
| 01/17/2002 | CA2351110A1 Helicobacter felis vaccine |
| 01/16/2002 | EP1172116A1 Pharmaceutical composition comprising anti-H.pylori urease IgY antibodies and an inhibitor of gastric acid secretion |
| 01/16/2002 | EP1172110A2 Use of lipoic acid as a bioavailaty enhancer of mineral salts |
| 01/16/2002 | EP1172106A2 Use of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles as substance P receptor antagonists |
| 01/16/2002 | EP1172105A1 Antifungal compositions |
| 01/16/2002 | EP1172103A2 Combination of 3-iodo-2-propynyl-butylcarbamate esters and one or more hydroxybenzoic acids |